TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.47, sa.3, ss.841-846, 2017 (SCI-Expanded)
Background/aim: This study aimed to evaluate the role of adjuvant therapy for stage I uterine leiomyosarcoma (LMS).